CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
Minhye Kim, Ji Min Na, Gyeong-Won Lee, Seung Jun Lee, Jong Duk Kim, Jung Wook Yang
JPTM. 2021;55(1):79-82.   Published online 2020 December 3    DOI: https://doi.org/10.4132/jptm.2020.11.02

Excel Download

EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
Journal of Pathology and Translational Medicine. 2021;55(1):79-82   Crossref logo
Link1 Link2 Link3

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3 -mutation, localized transformation to EGFR -mutated SCLC, and acquired T790M EGFR -mutation
Lung Cancer. 2017;113:14-17   Crossref logo
Link1 Link2

The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
OncoTargets and Therapy. 2021;Volume 13:13425-13435   Crossref logo
Link1 Link2

Afatinib
Reactions Weekly. 2018;1715(1):22-22   Crossref logo
Link1 Link2 Link3

ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer
Biomedical Research and Therapy. 2017;4(S):33   Crossref logo
Link1 Link2

Erlotinib
Reactions Weekly. 2017;1675(1):108-108   Crossref logo
Link1 Link2 Link3

Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case report
Thoracic Cancer. 2018;9(12):1774-1777   Crossref logo
Link1 Link2

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma

OncoTargets and Therapy. 2020;Volume 13:8317-8321   Crossref logo
Link1 Link2

T790M mutation in stage IV EGFR-mutated NSCLC patient with acquired resistance reverted to original 19Del mutation after administration of a series of precision treatments: a case report
Precision Clinical Medicine. 2018;1(3):129-133   Crossref logo
Link1

3075 Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs
European Journal of Cancer. 2015;51:S622   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.